Molecular marks for epigenetic identification of developmental and cancer stem cells
Open Access
- 17 December 2010
- journal article
- website
- Published by Springer Science and Business Media LLC in Clinical Epigenetics
- Vol. 2 (1), 27-53
- https://doi.org/10.1007/s13148-010-0016-0
Abstract
Epigenetic regulations of genes by reversible methylation of DNA (at the carbon-5 of cytosine) and numerous reversible modifications of histones play important roles in normal physiology and development, and epigenetic deregulations are associated with developmental disorders and various disease states, including cancer. Stem cells have the capacity to self-renew indefinitely. Similar to stem cells, some malignant cells have the capacity to divide indefinitely and are referred to as cancer stem cells. In recent times, direct correlation between epigenetic modifications and reprogramming of stem cell and cancer stem cell is emerging. Major discoveries were made with investigations on reprogramming gene products, also known as master regulators of totipotency and inducer of pluoripotency, namely, OCT4, NANOG, cMYC, SOX2, Klf4, and LIN28. The challenge to induce pluripotency is the insertion of four reprogramming genes (Oct4, Sox2, Klf4, and c-Myc) into the genome. There are always risks of silencing of these genes by epigenetic modifications in the host cells, particularly, when introduced through retroviral techniques. In this contribution, we will discuss some of the major discoveries on epigenetic modifications within the chromatin of various genes associated with cancer progression and cancer stem cells in comparison to normal development of stem cell. These modifications may be considered as molecular signatures for predicting disorders of development and for identifying disease states.Keywords
This publication has 164 references indexed in Scilit:
- Experimental approaches to the study of epigenomic dysregulation in ageingExperimental Gerontology, 2010
- LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast CancerCell, 2009
- Protein Arginine Methylation in Mammals: Who, What, and WhyMolecular Cell, 2009
- Genome Regulation by Polycomb and Trithorax ProteinsCell, 2007
- Chromatin Modifications and Their FunctionCell, 2007
- The Epigenomics of CancerCell, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem CellsCell, 2006
- Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinomaGenes, Chromosomes and Cancer, 2002
- Lung epithelial stem cellsThe Journal of Pathology, 2002